EUVIMEDEUVIMED entdecken
Open Access

Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in a syngeneic orthotopic mouse model of ovarian high-grade serous carcinoma

Jacob Haagsma, Yudith Ramos Valdes, Xuejin Ou, Rasheduzzaman Rashu, S M Mansour Haeryfar, Jim Petrik, Trevor G Shepherd

Oncotarget · 2025

DOI: 10.18632/oncotarget.28768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, 2025. Verfasst von Jacob Haagsma und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Mary and John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Centre, London, ON, Canada. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Tumor Suppressor Protein p53, Cystadenocarcinoma, Serous, T-Lymphocytes. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian high-grade serous carcinoma (HGSC) is an aggressive disease with an urgent need for improved therapies. Immunotherapies have proved useful for some cancers but have failed to provide benefits for HGSC. Improving our understanding of the mechanisms regulating the HGSC tumor microenvironment will facilitate the discovery of novel immunotherapies and help predict patient response. To this end, the development of syngeneic models is imperative to recapitulate immune responses observed in patients with HGSC. Yet, few syngeneic HGSC mouse models exist that accurately reflect the initiation and disease progression of human disease. In this study, we developed a syngeneic model reflecting both the site of origin and the genotype of early HGSC disease by deleting Trp53 in mouse oviductal epithelial (OVE) cells. Orthotopic injection of OVE cells demonstrated advanced disease progression due to loss of Trp53, associated with a less active T cell phenotype. Molecular analyses uncovered altered inflammatory signaling in OVE4-Trp53ko cells. Further analysis on an ascites-derived cell line identified selection for decreased pro-inflammatory signaling. These results highlight potential mechanisms by which loss of p53 function contributes to an immunosuppressive microenvironment in HGSC, and provide insight into the role of ovarian and peritoneal microenvironments in regulating HGSC cell-intrinsic inflammatory signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsTumor Suppressor Protein p53Cystadenocarcinoma, SerousT-LymphocytesAnimalsFemaleDisease Models, AnimalMiceSignal TransductionTumor MicroenvironmentHumansPhenotypeCell Line, TumorMice, KnockoutMice, Inbred C57BL

Stichwörter der Autor:innen

high-grade serous ovarian carcinomainflammationmicroenvironmentorthotopic models

Substanzen

Tumor Suppressor Protein p53Trp53 protein, mouse

Autor:innen und Institutionen

  • The Mary and John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Centre, London, ON, Canada.
  • Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
  • Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
  • Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Chengdu, China.
  • Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
  • Department of Surgery, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Zitieren

APA

Haagsma, J., Valdes, Y. R., Ou, X., Rashu, R., Haeryfar, S. M. M., Petrik, J., & Shepherd, T. G. (2025). Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in a syngeneic orthotopic mouse model of ovarian high-grade serous carcinoma. Oncotarget. https://doi.org/10.18632/oncotarget.28768

Vancouver

Haagsma J, Valdes YR, Ou X, Rashu R, Haeryfar SMM, Petrik J, et al. Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in a syngeneic orthotopic mouse model of ovarian high-grade serous carcinoma. Oncotarget. 2025. doi:10.18632/oncotarget.28768

BibTeX
@article{Haagsma2025,
  author = {Haagsma, Jacob and Valdes, Yudith Ramos and Ou, Xuejin and Rashu, Rasheduzzaman and Haeryfar, S M Mansour and Petrik, Jim and Shepherd, Trevor G},
  title = {Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in a syngeneic orthotopic mouse model of ovarian high-grade serous carcinoma},
  journal = {Oncotarget},
  year = {2025},
  doi = {10.18632/oncotarget.28768}
}
Kostenlos starten →